NK8 Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - NuVasive Inc - Alpha Spread
Have any thoughts about
NuVasive Inc?
Write Note

Wall Street
Price Targets

NK8 Price Targets Summary
NuVasive Inc

Wall Street analysts forecast NK8 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NK8 is 74.07 EUR .

Lowest
Price Target
Not Available
Average
Price Target
74.07 EUR
101% Upside
Highest
Price Target
Not Available
NuVasive Inc Competitors:
Price Targets
PEN
Penumbra Inc
1% Downside
7575
Japan Lifeline Co Ltd
17% Upside
DIA
DiaSorin SpA
2% Upside
PRN
Profound Medical Corp
59% Upside
4737
Bionime Corp
78% Upside
ITGR
Integer Holdings Corp
3% Upside
TNDM
Tandem Diabetes Care Inc
27% Upside
ZOM
Zomedica Corp
238% Upside

Revenue
Forecast

Revenue Estimate
NuVasive Inc

For the last 8 years the compound annual growth rate for NuVasive Inc's revenue is 6%.

6%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
NuVasive Inc

Operating Income forecast
is not available for
NuVasive Inc

Net Income
Forecast

Net Income Estimate
NuVasive Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NK8's stock price target?
Price Target
74.07 EUR

According to Wall Street analysts, the average 1-year price target for NK8 is 74.07 EUR .

Back to Top